BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5820134)

  • 1. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters].
    Stelzer M; Mertz DP
    Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
    Yamakido M; Yokoyama M; Noguchi S
    Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology and pathogenesis of iodine-induced thyrotoxicosis in Northern Tasmania.
    Stewart JC
    N Z Med J; 1975 Jan; 81(531):25-6. PubMed ID: 1055312
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 8. Endemic goiter in Western New Guinea. 3. Thyroid-stimulating activity of serum from severely iodine-deficient people.
    Adams DD; Kennedy TH; Choufoer JC; Querido A
    J Clin Endocrinol Metab; 1968 May; 28(5):685-92. PubMed ID: 5653202
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endemic goiter in Austria. Is iodine deficiency the primary cause of goiter?].
    Grubeck-Loebenstein B; Kletter K; Kiss A; Vierhapper H; Waldhäusl W
    Schweiz Med Wochenschr; 1982 Oct; 112(44):1526-30. PubMed ID: 7156942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid stimulating substances in human saliva.
    Sahadevan V; Field EO
    Strahlentherapie Sonderb; 1968; 67():425-35. PubMed ID: 4180681
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of various iodination procedures on the biological activity of LATS.
    Fenzi GF; Romaldini JH; Grasso L; Raccis E; Pinchera A; Baschieri L
    J Nucl Biol Med; 1972; 16(2):55-7. PubMed ID: 4662340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on hyperthyroidism with special references to clinical-statistical surveys and studies on 131-I-triiodothyronine resin sponge uptake test and long-acting thyroid stimulator (LATS)].
    Hayashida M
    Sapporo Igaku Zasshi; 1966 Dec; 30(6):292-320. PubMed ID: 6010790
    [No Abstract]   [Full Text] [Related]  

  • 18. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.